Consuelo Vega-Zambrano , Nikolaos A. Diangelakis , Vassilis M. Charitopoulos
{"title":"Data-driven model predictive control for continuous pharmaceutical manufacturing","authors":"Consuelo Vega-Zambrano , Nikolaos A. Diangelakis , Vassilis M. Charitopoulos","doi":"10.1016/j.ijpharm.2025.125322","DOIUrl":null,"url":null,"abstract":"<div><div>This study demonstrates that the development of interpretable, data-driven models for pharmaceutical continuous manufacturing is feasible using a machine learning method called Dynamic Mode Decomposition with Control (DMDc). This approach facilitates adoption within Good Manufacturing Practice (GMP)-regulated areas in the pharmaceutical industry. Furthermore, since the pharmaceutical industry needs to be more operationally efficient to be profitable and sustainable, we present a real-time monitoring strategy framework using an interpretable DMDc dynamic model for the design and tuning of a model predictive control (MPC) system for granule size control in a twin-screw granulation process. This model exhibits low computational complexity without requiring first principles knowledge, while effectively capturing nonlinear dynamics of this multiple input multiple output (MIMO) system, with enhanced performance (e.g., R<sup>2</sup> > 0.93 for D50 predictions) in the reconstruction of unseen test data in comparison with benchmark data-driven methods for system identification. The DMDc-MPC was implemented and tested on setpoint tracking and disturbance rejection and the proposed advanced process control framework guaranteed both.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"672 ","pages":"Article 125322"},"PeriodicalIF":5.3000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325001589","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This study demonstrates that the development of interpretable, data-driven models for pharmaceutical continuous manufacturing is feasible using a machine learning method called Dynamic Mode Decomposition with Control (DMDc). This approach facilitates adoption within Good Manufacturing Practice (GMP)-regulated areas in the pharmaceutical industry. Furthermore, since the pharmaceutical industry needs to be more operationally efficient to be profitable and sustainable, we present a real-time monitoring strategy framework using an interpretable DMDc dynamic model for the design and tuning of a model predictive control (MPC) system for granule size control in a twin-screw granulation process. This model exhibits low computational complexity without requiring first principles knowledge, while effectively capturing nonlinear dynamics of this multiple input multiple output (MIMO) system, with enhanced performance (e.g., R2 > 0.93 for D50 predictions) in the reconstruction of unseen test data in comparison with benchmark data-driven methods for system identification. The DMDc-MPC was implemented and tested on setpoint tracking and disturbance rejection and the proposed advanced process control framework guaranteed both.
期刊介绍:
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.